loader image
Friday, December 19, 2025
65.2 F
McAllen
- Advertisement -

Dealing with Endometriosis

Translate to Spanish or other 102 languages!

Endometriosis can start at a person’s first menstrual period and last until menopause. Image for illustration purposes
Endometriosis can start at a person’s first menstrual period and last until menopause. Image for illustration purposes
- Advertisement -

By Texas Tech University Health Sciences Center El Paso

Gynecology specialist Mary Ann Son, M.D. with Texas Tech Physicians of El Paso. Image Courtesy of  TTUHSC El Paso

Newswise — Endometriosis is a disease in which tissue similar to the lining of the uterus grows outside the uterus. It can cause severe pain in the pelvis, cystic growths in the ovaries and other organ spaces, and makes it harder to get pregnant.

  • Endometriosis affects roughly 10% (190 million) of reproductive age women and girls globally.
  • Endometriosis can start at a person’s first menstrual period and last until menopause.
  • It is a chronic disease associated with severe, life-impacting pain during periods, sexual intercourse, bowel movements and/or urination.
  • Access to early diagnosis and effective treatment of endometriosis is important.
  • It is important to schedule an exam with an Ob Gyn to determine if you are at risk.
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
Ă—